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SUPPLEMENTARY NOTES
ABSTRACT
The goals of this set experiments was to determine whether different concentrations of melatonin and DMSO along with 4M BHB would be as effective as our standard dosing regimen of 4M BHB/43mM Melatonin 20% DMSO. Based on the data presented data, our standard dosing regimen is the most effective treatment when compared to lower concentrations of melatonin DMSO in 4M BHB. 
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All animals in this set of experiments had the same amount of blood removed and received the same amount of resuscitative fluids (Figure 1 ). Animals receiving lower concentrations of Melatonin and DMSO had slightly less fluid requirements. However, this trend was not statistically significant. 
Conclusion:
The goal of this set of experiments was to determine whether lower concentrations of melatonin and DMSO would be more effective as standard of care.
Based on the data presented, animals treated with 4M BHB and either 10mM
Melatonin/5% DMSO or 20mM Melatonin/5% DMSO showed no survival benefit when compared to standard of care (lactated Ringers'treatment).
Publications, Abstracts, and Presentations:
• A manuscript entitled "Safety of D--ß--Hydroxybutyrate and Melatonin for the Treatment of Hemorrhagic Shock with Polytrauma" has been published at Shock. 
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